Olr696 inhibitors represent a fascinating class of chemical compounds that specifically target and inhibit the activity of the olfactory receptor 696 (Olr696). Olfactory receptors are a part of the G protein-coupled receptor (GPCR) superfamily, which plays a crucial role in detecting and transducing chemical signals in various biological processes. Olr696, being one of the many olfactory receptors, is involved in the binding and recognition of specific odorant molecules, initiating a cascade of cellular responses that ultimately lead to the perception of smell. The inhibition of Olr696 can significantly alter the olfactory signaling pathways, making it a valuable tool for studying the molecular mechanisms underlying olfaction. By selectively blocking the function of Olr696, researchers can elucidate its specific role and contribution to the olfactory system, advancing our understanding of how different odorants are detected and processed by the olfactory sensory neurons.
From a chemical standpoint, Olr696 inhibitors are structurally diverse, often comprising a range of organic molecules designed to fit precisely within the binding site of the receptor. These inhibitors may include small molecules, peptides, or even larger macromolecules, each tailored to interact with specific amino acid residues within the Olr696 receptor. The design and synthesis of Olr696 inhibitors involve detailed structural analyses, often employing techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to determine the receptor's three-dimensional conformation. Computational modeling and molecular docking studies are also frequently used to predict the binding affinity and specificity of potential inhibitors. The development of these inhibitors not only requires a deep understanding of the receptor's structure and function but also the application of advanced synthetic chemistry techniques to create compounds that are both potent and selective. Through continued research and development, Olr696 inhibitors will undoubtedly contribute to a deeper comprehension of olfactory receptor functionality and the broader principles of GPCR signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, potentially altering gene expression and protein function. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor, potentially impacting protein degradation and cell cycle regulation. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor, potentially disrupting proteins involved in cell growth and proliferation pathways. | ||||||
Afatinib-d4 | 850140-72-6 (unlabeled) | sc-481821 | 10 mg | $4665.00 | ||
EGFR inhibitor, potentially affecting proteins in EGFR-driven signaling pathways. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
PARP inhibitor, potentially disrupting DNA repair pathways and affecting protein function. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Multi-kinase inhibitor, potentially affecting proteins in angiogenesis, oncogenesis, and the tumor microenvironment. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor, potentially influencing apoptosis-related proteins. | ||||||